PYC pyc therapeutics limited

Evans and Partners have increased their current fair valuation,...

  1. 6,833 Posts.
    lightbulb Created with Sketch. 383
    Evans and Partners have increased their current fair valuation, to 44c. They have a 45% chance of success for PYC-001 now and included the priority review voucher in the calculations at the same risk.( So in 2030 45m out of US $100m which is still conservative considering the recent sale at $158m). They still have a 50m cap raise with dilution factored in but note that a deal would remove that and therefore add considerable value at the time of annct.
    Last edited by travelbug2: 02/09/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.27
Change
-0.020(1.56%)
Mkt cap ! $737.8M
Open High Low Value Volume
$1.29 $1.29 $1.25 $4.616M 3.649M

Buyers (Bids)

No. Vol. Price($)
2 19940 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.27 1008 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.